Prognostic impact of Ikaros expression in lenalidomide-treated multiple myeloma.

Oncotarget · 2017 · PMC5739718 · PMID 29290933

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients who achieved a complete response or very good partial response at the time point of best response showed a trend towards lower pretreatment IKZF1 expression levels compared with patients with a partial response or stable disease.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.